These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity. Uchibayashi N, Kikutani H, Barsumian EL, Hauptmann R, Schneider FJ, Schwendenwein R, Sommergruber W, Spevak W, Maurer-Fogy I, Suemura M. J Immunol; 1989 Jun 01; 142(11):3901-8. PubMed ID: 2523938 [Abstract] [Full Text] [Related]
8. Interleukin 4 dependent induction of IgE synthesis and CD23 expression by the supernatants of a human helper T cell clone. Vercelli D, Leung DY, Jabara HH, Geha RS. Int Arch Allergy Appl Immunol; 1989 Jun 01; 88(1-2):119-21. PubMed ID: 2523353 [Abstract] [Full Text] [Related]
16. Regulatory role of cytokines and CD23 in the human IgE antibody synthesis. Pène J. Int Arch Allergy Appl Immunol; 1989 Sep 01; 90 Suppl 1():32-40. PubMed ID: 2533178 [Abstract] [Full Text] [Related]
17. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Bujanowski-Weber J, Brings B, Knöller I, Pfeil T, König W. Immunology; 1989 Apr 01; 66(4):505-11. PubMed ID: 2523859 [Abstract] [Full Text] [Related]
18. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23). Delespesse G, Sarfati M, Peleman R. J Immunol; 1989 Jan 01; 142(1):134-8. PubMed ID: 2521231 [Abstract] [Full Text] [Related]
19. CD23: novel disease marker with a split personality. Gordon J. Clin Exp Immunol; 1991 Dec 01; 86(3):356-9. PubMed ID: 1836159 [No Abstract] [Full Text] [Related]